Teva Hit With Injunction In Evista Patent Suit V. Lilly

Law360, New York (April 23, 2009, 12:00 AM EDT) -- A judge has issued a preliminary injunction against Teva Pharmaceuticals USA Inc., barring the generic-drug maker from launching a copy of Eli Lilly and Co.'s blockbuster osteoporosis drug Evista amid an ongoing patent infringement trial.

Judge Sarah Evans Barker of the U.S. District Court for the Southern District of Indiana granted the injunction Wednesday, blocking Teva from marketing generic Evista until the court reaches its final ruling.

“Having found that Lilly has demonstrated a likelihood that it will succeed in demonstrating that the '086 patent is...
To view the full article, register now.